Literature DB >> 12958315

Ca2+-dependent modulation of intracellular Mg2+ concentration with amiloride and KB-R7943 in pig carotid artery.

Tadayuki Uetani1, Tatsuaki Matsubara, Hideki Nomura, Toyoaki Murohara, Shinsuke Nakayama.   

Abstract

It has long been recognized that magnesium is associated with several important diseases, including diabetes, hypertension, cardiovascular, and cerebrovascular diseases. In the present study, we measured the intracellular free Mg2+ concentration ([Mg2+]i) using 31P nuclear magnetic resonance (NMR) in pig carotid artery smooth muscle. In normal solution, application of amiloride (1 mm) decreased [Mg2+]i by approximately 12% after 100 min. Subsequent washout tended to further decrease [Mg2+]i. In contrast, application of amiloride significantly increased [Mg2+]i (by approximately 13% after 100 min) under Ca2+-free conditions, where passive Mg2+ influx is facilitated. The treatments had little effect on intracellular ATP and pH (pHi). Essentially the same Ca2+-dependent changes in [Mg2+]i were produced with KB-R7943, a selective blocker of reverse mode Na+-Ca2+ exchange. Application of dimethyl amiloride (0.1 mM) in the presence of Ca2+ did not significantly change [Mg2+]i, although it inhibited Na+-H+ exchange at the same concentration. Removal of extracellular Na+ caused a marginal increase in [Mg2+]i after 100-200 min, as seen in intestinal smooth muscle in which Na+-Mg2+ exchange is known to be the primary mechanism of maintaining a low [Mg2+]i against electrochemical equilibrium. In Na+-free solution (containing Ca2+), neither amiloride nor KB-R7943 decreased [Mg2+]i, but they rather increased it. The results suggest that these inhibitory drugs for Na+-Ca2+ exchange directly modulate Na+-Mg2+ exchange in a Ca2+-dependent manner, and consequently produce the paradoxical decrease in [Mg2+]i in the presence of Ca2+.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12958315     DOI: 10.1074/jbc.M307898200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Single-molecule studies of the lysine riboswitch reveal effector-dependent conformational dynamics of the aptamer domain.

Authors:  Larry R Fiegland; Andrew D Garst; Robert T Batey; David J Nesbitt
Journal:  Biochemistry       Date:  2012-10-30       Impact factor: 3.162

2.  Fidelity variants of RNA dependent RNA polymerases uncover an indirect, mutagenic activity of amiloride compounds.

Authors:  Laura I Levi; Nina F Gnädig; Stéphanie Beaucourt; Malia J McPherson; Bruno Baron; Jamie J Arnold; Marco Vignuzzi
Journal:  PLoS Pathog       Date:  2010-10-28       Impact factor: 6.823

3.  Low-magnesium, trans-cleavage activity by type III, tertiary stabilized hammerhead ribozymes with stem 1 discontinuities.

Authors:  Donald H Burke; S Travis Greathouse
Journal:  BMC Biochem       Date:  2005-08-12       Impact factor: 4.059

4.  Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus.

Authors:  Kang Yiu Lai; Wing Yiu George Ng; Fan Fanny Cheng
Journal:  Infect Dis Poverty       Date:  2014-11-28       Impact factor: 4.520

5.  Na(+)-independent Mg(2+) transport sensitive to 2-aminoethoxydiphenyl borate (2-APB) in vascular smooth muscle cells: involvement of TRPM-like channels.

Authors:  Yukihisa Hamaguchi; Tatsuaki Matsubara; Tetsuya Amano; Tadayuki Uetani; Haruhiko Asano; Takashi Iwamoto; Koichi Furukawa; Toyoaki Murohara; Shinsuke Nakayama
Journal:  J Cell Mol Med       Date:  2008-06       Impact factor: 5.310

6.  Imipramine inhibition of TRPM-like plasmalemmal Mg2+ transport in vascular smooth muscle cells.

Authors:  Yukihisa Hamaguchi; Yasushi Tatematsu; Koichi Furukawa; Tatsuaki Matsubara; Shinsuke Nakayama
Journal:  J Cell Mol Med       Date:  2011-03       Impact factor: 5.310

7.  Axonal protection achieved by blockade of sodium/calcium exchange in a new model of ischemia in vivo.

Authors:  Fengfeng Bei; Kenneth J Smith
Journal:  Neuropharmacology       Date:  2012-04-28       Impact factor: 5.250

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.